Your body already knows this molecule.
GHK-Cu (copper peptide GHK-Cu) is a naturally occurring tripeptide — glycine-histidine-lysine — with a high affinity for copper ions. It's found in human plasma, saliva, and urine, and its levels decline significantly with age: plasma GHK-Cu drops roughly 3-fold between age 20 and 60.
GHK-Cu activates a broad range of repair and regeneration processes. It stimulates collagen and elastin synthesis, promotes the growth of new blood vessels, activates fibroblasts (the cells responsible for connective tissue repair), and upregulates antioxidant enzymes. It also has a documented role in modulating gene expression — specifically, it appears to reset damaged or aged tissue toward a more youthful gene expression profile.
Research by Dr. Loren Pickart over several decades established much of the foundational science on GHK-Cu. More than 30 years of published research supports its role in skin repair, wound healing, and tissue regeneration.
For anyone investing in long-term skin health.
GHK-Cu is appropriate for anyone focused on skin quality, anti-aging, or wound healing. It's used both topically (in skincare applications) and systemically (subcutaneous or IV) for patients who want more comprehensive tissue effects.
Systemic GHK-Cu is particularly relevant for patients with a broader regenerative or anti-aging protocol, where skin is one of several targets alongside the effects on connective tissue throughout the body.
- Skin regeneration and repair
- Collagen and elastin synthesis
- Wound healing acceleration
- Reduction of fine lines and improved texture
- Connective tissue health throughout the body
- Anti-inflammatory gene expression modulation
Flexible, well-tolerated, cumulative.
GHK-Cu can be administered topically for localized skin effects, subcutaneously for systemic tissue effects, or in some protocols via IV. The choice depends on the patient's primary goals.
For systemic protocols, subcutaneous administration several times weekly is typical. Topical application can complement systemic dosing for patients focused on facial and skin outcomes. Results are cumulative and most clearly apparent after several weeks of consistent use.
| Route | Primary Target | Frequency |
|---|---|---|
| Topical | Skin, face, localized | Daily |
| Subcutaneous | Systemic tissue, skin | 3–5x weekly |
| IV | Systemic, acute tissue repair | Weekly to monthly |
What you should know
GHK-Cu has an excellent safety profile. It's a naturally occurring peptide that the body already produces, and it's been used in cosmetic and pharmaceutical research for decades.
Injection site reactions and mild transient redness are the most commonly reported side effects. Topical application is extremely well tolerated. There are no significant known systemic side effects at therapeutic doses.
Common questions about GHK-Cu
Related, but not the same. Topical copper peptide products contain GHK-Cu at concentrations that affect the skin surface. Systemic GHK-Cu through subcutaneous injection delivers the peptide throughout the body, affecting connective tissue systemically — not just the skin you can apply a cream to.
Different mechanism, different risk profile. Retinoids work primarily by accelerating cell turnover and regulating gene expression. GHK-Cu promotes collagen synthesis, activates fibroblasts, and has antioxidant effects. They can be complementary rather than competing.
Skin changes from collagen synthesis take time — most patients begin to notice texture and quality improvements at 6–8 weeks, with more meaningful changes at 12–16 weeks. This is consistent with the biology: new collagen production and remodeling is a slow process.
Yes. GHK-Cu's effects on fibroblasts, connective tissue, and gene expression modulation are relevant beyond skin — tissue repair, anti-inflammatory effects, and potentially neuroprotective properties are areas of ongoing research.
We review your labs, goals, and health history before recommending any protocol. Available in-person in St. Louis or via secure telehealth.
📅 Request a Consultation →